n-methyl-d-glucamine dithiocarbamate has been researched along with 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Desole, MS; Esposito, G; Grella, G; Marchetti, B; Miele, E; Miele, M; Migheli, R; Mura, MP; Rocchitta, G; Serra, PA | 1 |
1 other study(ies) available for n-methyl-d-glucamine dithiocarbamate and 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole
| Article | Year |
|---|---|
Signaling pathways in the nitric oxide and iron-induced dopamine release in the striatum of freely moving rats: role of extracellular Ca2+ and L-type Ca2+ channels.
Topics: Animals; Benzoates; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Signaling; Corpus Striatum; Dopamine; Extracellular Fluid; Imidazoles; Iron; Iron Chelating Agents; Male; Microdialysis; Movement; Nitric Oxide; Nitric Oxide Donors; Presynaptic Terminals; Rats; Rats, Wistar; Sorbitol; Spin Labels; Synaptic Transmission; Thiocarbamates; Wakefulness | 2005 |